Ageing - Pipeline Insight, 2019

Array
(
    [id] => 1052377
    [discount] => PDF-20-Site Licence-30-ENTERPRISE WIDE LICENCE-40----
    [isbn] => 
    [title] => Ageing - Pipeline Insight, 2019
    [upcommingtext] => 
    [seo_url] => ageing-pipeline-insight
    [shortdesc] => 
    [meta_title] => Ageing - Pipeline Insight, 2019
    [keyword] => 
Ageing Pipeline Drugs
 Ageing Pipeline Assessment
 Ageing Pipeline Analysis
 Ageing Drugs under Development
 Ageing Discovery drugs
 Ageing Preclinical drugs
 Ageing Phase I drugs
 Ageing Phase II drugs
 Ageing Phase III Pipeline Drugs Assessment
 Ageing Preregistration drugs
 Ageing Molecules in pipeline

    [description] =>  Ageing - Pipeline Insight, 2019 report  offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ageing development. The report provides detailed coverage of the
    [curr] => USD
    [category] => 1236
    [publisher] => 99
    [published_date] => 2019-01-01
    [country] => 230
    [author_name] => 
    [page_num] => 50
    [abstract] => "Ageing - Pipeline Insight, 2019” report  offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ageing development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. 

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Ageing
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Ageing
The report assesses the active Ageing pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis ’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Ageing
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Ageing
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ageing
• The report also covers the dormant and discontinued pipeline projects related to the Ageing

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Ageing to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Ageing therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress
[table_of_contents] => 1. Report Introduction
2. Ageing Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Ageing
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
[list_of_tables] => Table 1: Total Products for Ageing
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products
[list_of_figures] => Figure 1: Total Products for Ageing
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
[sample_page] => [brochure] => [new_price] => PDF-1250-Site License-2500-Enterprise Wide Licence-4000-Multi User Licence--Enterprise Wide Licence--Enterprise Wide Licence--Multi User Licence- )
discount aarkstore
"Ageing - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ageing development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
Clinical
Non-clinical
Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Ageing
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Ageing
The report assesses the active Ageing pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
The report provides a snapshot of the pipeline development for the Ageing
The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Ageing
The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ageing
The report also covers the dormant and discontinued pipeline projects related to the Ageing

Reasons to Buy
Establish comprehensive understanding of the pipeline activity across this Ageing to formulate effective R&D strategies
Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Ageing therapeutics
Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress
1. Report Introduction
2. Ageing Overview
3. Pipeline Therapeutics
An Overview of Pipeline Products for Ageing
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List Of Tables

Table 1: Total Products for Ageing
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List Of Figures

Figure 1: Total Products for Ageing
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

North America Anti Ageing Drugs Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Anti Ageing Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Global Anti Ageing Drugs Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Anti Ageing Drugs is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

USD 4000 View Report

Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H1 2020

Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H1 2020According to the recently published report Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H1 2020; Calcitonin

USD 3500 View Report

Free Fatty Acid Receptor 4 - Pipeline Review, H1 2020

Free Fatty Acid Receptor 4 - Pipeline Review, H1 2020Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available